Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
Actual shortage: | 54 (12%) | |
Anticipated shortage: | 15 (3%) | |
Avoided shortage: | 8 (2%) | |
Resolved: | 368 (83%) | |
Discontinuation Reports |
68 |
|
To be discontinued: | 7 (10%) | |
Discontinued: | 51 (75%) | |
Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (16%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ALENDRONATE | 70MG | TABLET | Resolved | 2022-01-19 | 2022-07-06 | 153051 |
OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-11-27 | 2018-12-11 | 30725 |
OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-03-27 | 2022-08-30 | 79597 |
OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-09-13 | 2018-11-16 | 21992 |
OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-03-27 | 2024-03-02 | 79600 |
OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-06-06 | 2018-09-28 | 12095 |
OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-09-13 | 2018-09-28 | 21989 |
OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-01-14 | 2024-02-27 | 103271 |
ROPINIROLE | 0.25MG | TABLET | Resolved | 2017-09-27 | 2017-10-16 | 23677 |
ROPINIROLE | 0.25MG | TABLET | Resolved | 2017-11-21 | 2017-12-16 | 29895 |
ROPINIROLE | 0.25MG | TABLET | Resolved | 2019-01-15 | 2019-02-28 | 72242 |
ROPINIROLE | 0.25MG | TABLET | Resolved | 2019-06-19 | 2019-09-07 | 87069 |
ROPINIROLE | 0.25MG | TABLET | Resolved | 2019-12-11 | 2020-02-04 | 100962 |
ROPINIROLE | 0.25MG | TABLET | Resolved | 2021-08-03 | 2021-10-01 | 143442 |
ROPINIROLE | 0.25MG | TABLET | Resolved | 2021-10-08 | 2024-02-15 | 146947 |
ROPINIROLE | 1MG | TABLET | Resolved | 2020-02-27 | 2020-04-08 | 107312 |
ROPINIROLE | 1MG | TABLET | Resolved | 2021-08-03 | 2022-04-05 | 143447 |
ROPINIROLE | 1MG | TABLET | Resolved | 2021-10-08 | 2022-04-06 | 146927 |
TERBINAFINE | 250MG | TABLET | Resolved | 2019-08-06 | 2019-10-02 | 90836 |
MELOXICAM | 7.5MG | TABLET | Resolved | 2019-05-30 | 2022-08-30 | 85269 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
TERAZOSIN | 10MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151275 |
TERAZOSIN | 1MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151278 |
TERAZOSIN | 2MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151281 |
TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
DILTIAZEM CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2412 |
DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
LORAZEPAM | 0.5MG | TABLET | Reversed | 2017-03-14 | 2017-07-31 | 2430 |
CLINDAMYCIN | 150MG | CAPSULE | Reversed | 2017-03-31 | 2017-07-31 | 4950 |
CLINDAMYCIN | 300MG | CAPSULE | Reversed | 2017-03-31 | 2017-07-31 | 4956 |
DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |
INDAPAMIDE | 1.25MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2453 |
RAMIPRIL-HCTZ | 12.5MG 10.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3023 |